BDRX Biodexa Pharmaceuticals Plc
Healthcare$3.28+1.23%ClosedMarket Cap: $550,243
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.01
P/S
0.00
EV/EBITDA
0.93
DCF Value
$211.51
FCF Yield
-1381.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-55.8%
ROA
-35.1%
ROIC
-72.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | -Infinity% | $-4.7M | $-2.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-8.3M | $-6.2M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-4.0M | $-3.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-5.0M | $-2.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-9.2M | $-5.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-4.2M | $-3.3M | $— | — |
| Q4 null | $83.0K | -2612.0% | $-3.8M | $-3.5M | $— | — |
| FY null | $381.0K | -967.5% | $-8.0M | $-7.1M | $— | — |
| Q2 null | $298.0K | -655.4% | $-4.2M | $-3.6M | $— | — |
| Q4 null | $231.0K | -1068.0% | $-3.8M | $-4.6M | $— | — |
| FY null | $699.0K | -631.2% | $-8.9M | $-7.7M | $— | — |
| Q2 null | $468.0K | -415.6% | $-3.8M | $-3.1M | $— | — |